- Investing Ideas
- /
- Global Pharmaceuticals & Biotech Most Popular Stocks
Global Pharmaceuticals & Biotech Most Popular Stocks
Results
3214
0 new
Most Popular Stocks on the market
3,214 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
LLY | US$773.84 | -2.8% | 32.8% | US$705.2b | US$984.05 | PE83.2x | E29.8% | 0.8% | ||
NOVO B | DKK 624.20 | 0.3% | -10.6% | DKK 2.8t | DKK 898.09 | PE29.2x | E14.2% | 1.6% | ||
JNJ | US$143.34 | -1.3% | -8.5% | US$349.2b | US$174.28 | PE23.4x | E10.6% | 3.5% | ||
ABBV | US$176.20 | -1.2% | 13.7% | US$314.6b | US$202.54 | PE61.3x | E28.0% | 3.7% | ||
MRK | US$98.37 | -1.0% | -9.8% | US$252.2b | US$128.73 | PE20.5x | E16.0% | 3.3% | ||
ROG | CHF 255.50 | 1.8% | 4.5% | CHF 205.2b | CHF 303.36 | PE19.2x | E11.5% | 3.8% | ||
AZN | UK£104.08 | -0.1% | -1.8% | UK£161.4b | UK£139.39 | PE31.1x | E18.2% | 2.2% | ||
TMO | US$518.84 | -1.2% | -2.3% | US$201.2b | US$649.80 | PE32.3x | E11.5% | 0.3% | ||
NOVN | CHF 88.70 | 1.2% | 4.5% | CHF 177.3b | CHF 103.92 | PE16.6x | E7.0% | 3.7% | ||
DHR | US$229.65 | 0.2% | -0.7% | US$166.9b | US$287.70 | PE42.2x | E13.4% | 0.5% | ||
PFE | US$26.42 | -1.1% | -8.2% | US$150.9b | US$31.86 | PE35x | E14.8% | 6.5% | ||
AMGN | US$259.30 | -1.8% | -10.0% | US$141.2b | US$322.43 | PE33x | E18.5% | 3.7% | ||
SAN | €93.14 | 1.5% | 3.8% | €116.8b | €113.80 | PE25.9x | E16.8% | 4.0% | ||
GILD | US$92.01 | -1.5% | 13.6% | US$117.3b | US$98.92 | PE910.1x | E40.7% | 3.3% | ||
BMY | US$56.06 | -2.6% | 9.3% | US$117.0b | US$60.91 | PS2.4x | E48.7% | 4.4% | ||
VRTX | US$399.35 | -1.5% | -1.9% | US$105.3b | US$493.61 | PS9.7x | E47.5% | n/a | ||
CSL | AU$281.58 | 0.3% | -2.3% | AU$136.3b | AU$340.56 | PE32.1x | E13.0% | 1.5% | ||
REGN | US$702.59 | -1.8% | -20.0% | US$76.6b | US$1,053.08 | PE16.2x | E6.9% | n/a | ||
ZTS | US$162.24 | -1.2% | -17.8% | US$74.3b | US$213.01 | PE30.1x | E10.0% | 1.2% | ||
4519 | JP¥6,999.00 | 1.7% | 31.0% | JP¥11.5t | JP¥7,416.67 | PE29.8x | E5.9% | 1.2% | ||
GSK | UK£13.34 | 0% | -8.0% | UK£54.4b | UK£18.17 | PE21.7x | E23.2% | 4.3% | ||
MRK | €139.90 | 1.5% | -2.9% | €60.8b | €183.75 | PE22.6x | E11.1% | 1.6% | ||
SUNPHARMA | ₹1,883.90 | 3.8% | 49.5% | ₹4.5t | ₹2,047.11 | PE40.9x | E12.7% | 0.7% | ||
4568 | JP¥4,352.00 | -0.7% | 12.4% | JP¥8.2t | JP¥6,333.33 | PE32.7x | E18.4% | 1.4% |